Patients

A new and innovative way to improve patients’ recoveries following colorectal surgery.

Professionals

An innovative and secure solution for the protection of digestive anastomosis.

Patients Benefits

Colovac device - Safeheal

Clinical

Invented by French surgeon Charam Khosrovani, Colovac is a flexible endoluminal bypass sheath that prevents contamination of the colorectal anastomotic site following open or laparoscopic colorectal surgery.

The company

Safeheal - Notre équipe

Who we are

Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy.

We are guided by compassion and empathy.

Testimonials

We are proud of our testimonials and comments we received from most valuable medical professionals.

Antonio d'Urso - Safeheal

Dr. Antonio D’Urso

Digestive surgery and bariatric at Hôpitaux Universitaires de Strasbourg, France

"In order to always improve the quality of life of our patients, our hospital has agreed to be part of the clinical study. I am a huge advocate of the Colovac: it enables to avoid diverting stoma, it is minimally invasive and fully reversible at any time."

Read More

Prof. Jérémie Lefevre

General Surgery at Hôpital Saint-Antoine, Paris-France

“The clinical results in this trial indicate that Colovac is an alternative to ileostomy, obviating the burden of stoma care for patients with a rectal cancer.”

Read More

Dr. Patricia Sylla

Colon and Rectal Surgery at Mount Sinai, New York-USA

"There is a clinical need, Colovac’s approaching the problem from a different angle. For the patient, there is an immediate added value: avoiding an ostomy, it is an added value, no matter what."

Read More

Recent News

  • SafeHeal Closes €40 Million Financing Co-Led by Sofinnova Partners and Genesis MedTech To Finance Its Colovac Device Through a Pivotal Clinical Trial in the United States : Click here to read the press release 
    SafeHeal lève 40 M€ lors d’un tour de table mené par Sofinnova Partners et Genesis Medtech Group pour financer l’étude clinique pivot de son produit Colovac : Cliquez ici pour lire le communiqué
  • Video: Innovations Santé

Please fill in the contact form and we will be happy to assist you